PATENT CLAIM ANALYSIS

Application Number: 16007151
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-10
Patent Classification: ["544", "360000"]

Abstract:
Provided are compounds that target the lanthionine synthetase C-like protein 2 pathway. The compounds can be used to treat a number of conditions, including infectious disease, autoimmune disease, diabetes, and a chronic inflammatory disease.

Claim (Index 42):
A method of treating a condition in an animal with a compound as recited in  claim 33 , the method comprising administering an effective amount of the compound to the animal, wherein the condition is selected from the group consisting of inflammatory bowel disease, diabetes, and influenza infection.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 94.0
- Lexical Diversity: 1.25
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15795906', '15374556', '14662506', '13100795', '15502105']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7911716560592695
- 35 USC 102 Novelty (BERT): 0.6279872145453134
- Combined Prediction Score: 0.7748532119078739
- Mean Citation Score: 500.533792
- Max Citation Score: 649.8839
- Similarity Product: 517.2082675212622

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test